431 related articles for article (PubMed ID: 25689371)
1. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Baghdadi LR; Woodman RJ; Shanahan EM; Mangoni AA
PLoS One; 2015; 10(2):e0117952. PubMed ID: 25689371
[TBL] [Abstract][Full Text] [Related]
2. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
Naranjo A; Sokka T; Descalzo MA; Calvo-Alén J; Hørslev-Petersen K; Luukkainen RK; Combe B; Burmester GR; Devlin J; Ferraccioli G; Morelli A; Hoekstra M; Majdan M; Sadkiewicz S; Belmonte M; Holmqvist AC; Choy E; Tunc R; Dimic A; Bergman M; Toloza S; Pincus T;
Arthritis Res Ther; 2008; 10(2):R30. PubMed ID: 18325087
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
[TBL] [Abstract][Full Text] [Related]
6. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes GT; Mallion JM; Ruilope L; Wedel H
J Hypertens; 2001 Jun; 19(6):1149-59. PubMed ID: 11403365
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: A systematic review and meta-analysis.
Wang H; Li X; Gong G
Medicine (Baltimore); 2020 Apr; 99(14):e19658. PubMed ID: 32243398
[TBL] [Abstract][Full Text] [Related]
8. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.
Avina-Zubieta JA; Thomas J; Sadatsafavi M; Lehman AJ; Lacaille D
Ann Rheum Dis; 2012 Sep; 71(9):1524-9. PubMed ID: 22425941
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L
Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Ferdinand KC; Botros FT; Atisso CM; Sager PT
Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
[TBL] [Abstract][Full Text] [Related]
12. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular disease in rheumatoid arthritis.
Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
[TBL] [Abstract][Full Text] [Related]
14. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.
Liao KP; Solomon DH
Rheumatology (Oxford); 2013 Jan; 52(1):45-52. PubMed ID: 22986289
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular morbidity and mortality in rheumatoid arthritis.
Gabriel SE
Am J Med; 2008 Oct; 121(10 Suppl 1):S9-14. PubMed ID: 18926169
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.
Barnabe C; Martin BJ; Ghali WA
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):522-9. PubMed ID: 20957658
[TBL] [Abstract][Full Text] [Related]
18. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis.
Boyer JF; Gourraud PA; Cantagrel A; Davignon JL; Constantin A
Joint Bone Spine; 2011 Mar; 78(2):179-83. PubMed ID: 20851020
[TBL] [Abstract][Full Text] [Related]
19. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
Schieir O; Tosevski C; Glazier RH; Hogg-Johnson S; Badley EM
Ann Rheum Dis; 2017 Aug; 76(8):1396-1404. PubMed ID: 28219882
[TBL] [Abstract][Full Text] [Related]
20. Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis.
Savarese G; D'Amore C; Federici M; De Martino F; Dellegrottaglie S; Marciano C; Ferrazzano F; Losco T; Lund LH; Trimarco B; Rosano GM; Perrone-Filardi P
Int J Cardiol; 2016 Oct; 220():595-601. PubMed ID: 27390996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
